| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |